Endogenous opioid peptides: multiple agonists and receptors
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
Opioid peptides were assayed by inhibition of 3H-naloxone and 3H-leu-enkephalin binding in brain homogenates and by depression of contractions of the guinea pig ileum and mouse vas deferens. We conclude that the opioid peptidergic system has agonists of different characteristics which interact with more than one type of receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher order brain regions (PFC; rACC) project to the PAG, the rostral ventral medulla, and the dorsal horn of the spinal cord to reduce the elaboration of spinal and supraspinal nociceptive processing through the release of endogenous opioids9,77,78 that largely bind with mu, delta, and kappa receptors.54,69”
From The neural mechanisms of mindfulness-based pain relief: a functional magnetic resonance imaging-based review and primer (2019) · cites this paper as [69]
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Self-citationMartin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Opiate Receptor: Demonstration in Nervous Tissue
Pert, C. B., & Snyder, S. H. (1973) · Science · doi:10.1126/science.179.4077.1011 · Cited by 2,388
Opiates and endogenous opioid peptides
Kelly, J. S., & Dingledine, R. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90262-6 · Cited by 1,282
Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate
Simon, E. J., Hiller, J. M., & Edelman, I. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.7.1947 · Cited by 1,067
Elde, R., Hökfelt, T., Johansson, O., & Terenius, L. (1976) · Neuroscience · doi:10.1016/0306-4522(76)90063-4 · Cited by 775
C fragment of lipotropin has a high affinity for brain opiate receptors
BRADBURY, A. F., SMYTH, D. G., SNELL, C. R., BIRDSALL, N. J. M., & HULME, E. C. (1976) · Nature · doi:10.1038/260793a0 · Cited by 489
Gilbert, P. E., & Martin, W. R. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30572-0 · Cited by 487
Choline esters in tissue extracts
Chang, H. C., & Gaddum, J. H. (1933) · The Journal of Physiology · doi:10.1113/jphysiol.1933.sp003049 · Cited by 486
[D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide Analgesic
Pert, C. B., Pert, A., Chang, J.-K., & Fong, B. T. (1976) · Science · doi:10.1126/science.968485 · Cited by 469
Research works printed but not linked: 14
- Guillemin, R., Ling, N. & Burgus, R. C. r. hebd. Sèanc. Acad. Sci., Paris D274, 783–785 (1976).
- Waterfield, A. A., Smokcum, R. W. J., Hughes, J., Kosterlitz, H. W. & Henderson, G. Eur. J. Pharmac. (in the press).
- Martin, W. R., Pharmac Rev. 19, 463–521 (1967).
- Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert P. E. J. Pharmac. exp. Ther. 197, 517–532 (1976).
- Gilbert, P. E. & Martin, W. R. J. Pharmac. exp. Ther. 198, 66–82 (1976).
- Kosterlitz, H. W. & Watt, A. J. Br. J. Pharmac. 33, 266–276 (1968).
- Martin, W. R., Bell, J. A., Gilbert, P. E., Sloan, J. W. & Thompson, J. A. in Narcotic Antagonists: Naltrexone. NIDA Research Monograph 9 (ed. Julius, D & Renault, P.) 27–30 (Department of Health, Education and Welfare, Washington, D.C., 1976).
- Feldberg, W. & Smyth, D. G. J. Physiol., Lond. 260, 30P–31P (1976); 265, 25P–27P (1977).
- Pert, A. in Opiates and Endogenous Opioid Peptides(ed. Kosterlitz, H. W.) 87–94 (North-Holland, Amsterdam, 1976).
- Arunlakshana, O. & Schild, H. O. Br. J. Pharmac. 14, 48–58 (1959).
- Creese, I. & Snyder, S. H. J. Pharmac. exp. Ther. 194, 205–219 (1975).
- Simantov, R. & Snyder, S. H. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 41–48 (North-Holland, Amsterdam, 1976).
- Smith, T. W., Hughes, J., Kosterlitz, H. W. & Sosa, R. P. in Opiates and Endogenous Opioid Peptides (ed. Kosterlitz, H. W.) 57–62 (North-Holland, Amsterdam, 1976).
- Simantov, R., Kuhar, M. J. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. (in the press).
Cited by
Items 201–300 of 1,002
Demonstration and Characterization of Opiate Inhibition of the Striatal Adenylate Cyclase
Law, P., Wu, J., Koehler, J. E., & Loh, H. H. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb00438.x · Cited by 148
Multiple opiate receptors in peripheral tissue preparations
Wüster, M., Schulz, R., & Herz, A. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90194-5 · Cited by 149
In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord
Tung, A. S., & Yaksh, T. L. (1982) · Brain Research · doi:10.1016/0006-8993(82)91029-0 · Cited by 147
Organismic variables and pain inhibition: Roles of gender and aging
Bodnar, R. J., Romero, M.-T., & Kramer, E. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90032-9 · Cited by 159
Ribeiro, S. C. M., Kennedy, S. E., Smith, Y. R., Stohler, C. S., & Zubieta, J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.011 · Cited by 166
“…et al., 2002; Hong et al., 2004), named mu (A, for morphine), kappa (n, for ketocyclazocine) (Martin et al., 1976), delta (y, for vas deferens) (Lord et al., 1977), and ORL-1 (for opioid receptor-like) (Bunzow et al., 1994; Chen et al., 1994; Fukuda et al., 1994; Mollereau et al., 1994; Wang…”
BackgroundChallenges for opioid receptor nomenclature: IUPHAR Review 9
Cox, B. M., Christie, M. J., Devi, L., Toll, L., & Traynor, J. R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12612 · Cited by 145
“The well-established Greek symbol terminology, μ, δ and κ, for the first three types of opioid receptors to be identified was proposed by Bill Martin, Hans Kosterlitz and their co-workers (Gilbert and Martin, 1976; Martin et al., 1976; Lord et al., 1977) in the mid-1970s.”
BackgroundCoutts, A. A., & Pertwee, R. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701301 · Cited by 145
“The KD value of 2.38 nM (pA2 of 8.62) found for the antagonism of normorphine by naloxone agrees well with that previously published in the literature (Lord et al., 1977).”
ResultInfluentialMorphine activation of c-fos expression in rat brain
Chang, S. L., Squinto, S. P., & Harlan, R. E. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80306-1 · Cited by 145
Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon
Kalivas, P. W. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90004-1 · Cited by 145
Endogenous morphine and related opiates, a new class of chemical messengers
Stefano, G. B., & Scharrer, B. (1994) · Advances in Neuroimmunology · doi:10.1016/s0960-5428(05)80001-4 · Cited by 144
Opioid Actions on Membrane Ion Channels
North, R. A. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77460-7_30 · Cited by 160
Negus, S. S., Gatch, M. B., Mello, N. K., Zhang, X., & Rice, K. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37596-2 · Cited by 137
Deakin, J. F. W., Dostrovsky, J. O., & Smyth, D. G. (1980) · Biochemical Journal · doi:10.1042/bj1890501 · Cited by 161
Increase in potencies of opioid peptides after peptidase inhibition
McKnight, A. T., Corbett, A. D., & Kosterlitz, H. W. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90189-9 · Cited by 142
Self-citationPharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors
Maguire, P. A., Tsai, N. F., Kamal, J., Cometta–Morini, C., Upton, C., & Loew, G. H. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90685-w · Cited by 141
Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary.
Fischli, W., D, A. G. M., Hunkapiller, M. W., & Hood, L. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5435 · Cited by 141
Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice
Heyman, J. S., Mulvaney, S. A., Mosberg, H. I., & Porreca, F. (1987) · Brain Research · doi:10.1016/0006-8993(87)90244-7 · Cited by 140
Rossier, J., Bayón, A., Vargo, T. M., LING, N. C., Guillemin, R., & Bloom, F. E. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90414-3 · Cited by 141
Minireview opiates, opioid peptides and single neurones
North, R. A. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90014-6 · Cited by 140
Broadbear, J. H., Negus, S. S., Butelman, E. R., de Costa, B. R., & Woods, J. H. (1994) · Psychopharmacology · doi:10.1007/bf02245071 · Cited by 148
“-Funaltrexamine - Kappa antagonists - Acetic acid-induced writhing - Mice There is much experimental evidence supporting the premise that opioid effects are mediated by at least three opioid receptor types: mu and kappa (Martin et al 1976) and delta (Lord et al. 1977).”
Morphine and endorphins modulate dopamine turnover in rat median eminence.
Deyo, S. N., Swift, R. M., & Miller, R. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.6.3006 · Cited by 139
Attali, B., Gouardères, C., Mazarguil, H., Audigier, Y., & Cros, J. (1982) · Neuropeptides · doi:10.1016/0143-4179(82)90065-8 · Cited by 139
Chen, X.-H., & Han, J. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90530-h · Cited by 138
Endorphins in Psychiatry: An Overview and a Hypothesis
Verebey, K. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310083006 · Cited by 138
Evidence for vagal enkephalinergic neural control of the feline pylorus and stomach
Edin, R., Lundberg, J. O., Terenius, L. Y., Dahlström, A. B., Hökfelt, T. G. M., Kewenter, J., & Ahlman, H. K. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90862-8 · Cited by 138
β-Endorphin: cellular localization, electrophysiological and behavioral effects
Bloom, F. E., Rossier, J., Battenberg, E. L. F., Bayón, A., French, E. D., Henriksen, S. J., Siggins, G. R., LING, N. C., & Guillemin, R. (1979) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-04015-5_2 · Cited by 139
The effect of halogenation on blood–brain barrier permeability of a novel peptide drug☆
Gentry, C. L., Egleton, R. D., Gillespie, T., Abbruscato, T. J., Bechowski, H. B., Hruby, V. J., & Davis, T. P. (1999) · Peptides · doi:10.1016/s0196-9781(99)00127-8 · Cited by 150
Zöllner, C., & Stein, C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_2 · Cited by 163
Krieger, D. T., & Martin, J. B. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041505 · Cited by 135
ZADINA, J. E., MARTIN‐SCHILD, S., GERALL, A. A., KASTIN, A. J., HACKLER, L., GE, L., & ZHANG, X. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07885.x · Cited by 136
Moskowitz, A. S., & Goodman, R. R. (1985) · Brain Research · doi:10.1016/0006-8993(85)91226-0 · Cited by 134
Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus
Chesselet, M., Chéramy, A., Reisine, T., & Glowinski, J. (1981) · Nature · doi:10.1038/291320a0 · Cited by 135
Moskowitz, A., & Goodman, R. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-05-01331.1984 · Cited by 135
BILLAH, M. M., & Michell, R. H. (1979) · Biochemical Journal · doi:10.1042/bj1820661 · Cited by 135
Stress-induced behavioral responses and multiple opioid systems in the brain
Yamada, K., & Nabeshima, T. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00150-e · Cited by 144
Jensen, T. S., & Yaksh, T. L. (1986) · Brain Research · doi:10.1016/0006-8993(86)91138-8 · Cited by 134
Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptors
Oka, T., Negishi, K., Suda, M., Sawa, A., Fujino, M., & Wakimasu, M. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90008-5 · Cited by 133
Met- and Leu-enkephalin immunoreactivity in separate neurones
Larsson, L., Childers, S. R., & Snyder, S. H. (1979) · Nature · doi:10.1038/282407a0 · Cited by 131
Cunningham, S. T., & Kelley, A. E. (1992) · Brain Research · doi:10.1016/0006-8993(92)91349-j · Cited by 137
Okude, J., Ueda, T., Kofuku, Y., Sato, M., Nobuyama, N., Kondo, K., Shiraishi, Y., Mizumura, T., Onishi, K., Natsume, M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508794 · Cited by 137
Involvement of endorphins in emotional hyperthermia of rats
Bläsig, J., Höllt, V., Bäuerle, U., & Herz, A. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90179-0 · Cited by 135
Opioid Peptides and their Receptors
Kosterlitz, H. W., Paterson, S. J., & Robson, L. E. (1982) · Elsevier eBooks · doi:10.1016/b978-0-08-028021-9.50005-8 · Cited by 132
Self-citationEnkephalinase: Selective peptide inhibitors
Hudgin, R. L., Charleson, S. E., Zimmerman, M. D., Mumford, R. A., & Wood, P. L. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90632-9 · Cited by 132
Effect of naloxone upon diffuse noxious inhibitory controls (DNIC) in the rat
Bars, D. L., Chitour, D., Kraus, E., Dickenson, A. H., & Besson, J. M. (1981) · Brain Research · doi:10.1016/0006-8993(81)90597-7 · Cited by 132
Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus
Chavkin, C., & Goldstein, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7253 · Cited by 128
The μ-opioid receptor is necessary for [d-Pen2,d-Pen5]enkephalin-induced analgesia
Sora, I., Funada, M., & Uhl, G. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)10016-4 · Cited by 129
Smith, J. R., & Simón, E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.281 · Cited by 127
Schulz, R., Wüster, M., Krenss, H., & Herz, A. (1980) · Nature · doi:10.1038/285242a0 · Cited by 128
Morinville, A., Cahill, C. M., Esdaile, M. J., Aibak, H., Collier, B., Kieffer, B. L., & Beaudet, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04888.2003 · Cited by 146
“Pharmacological (Martin et al., 1976; Lord et al., 1977) and molecular cloning (Evans et al.”
BackgroundIdentification of a human delta opioid receptor: Cloning and expression
Knapp, R. J., Malatyńska, E., Fang, L., Li, X., Babin, E., Nguyen, M., Santoro, G., Varga, E. V., Hruby, V. J., Roeske, W. R., et al. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90138-4 · Cited by 124
A human neuroblastoma cell line expresses mu and delta opioid receptor sites.
Yu, V. C. K., Richards, M. L., & Sadée, W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36053-2 · Cited by 126
Ling, G. S. F., Paúl, D., Simantov, R., & Pasternak, G. W. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90272-5 · Cited by 125
CYTOTOXIC-THERAPY-INDUCED VOMITING IS MEDIATED VIA ENKEPHALIN PATHWAYS
Harris, A. L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92625-3 · Cited by 125
A cyclic enkephalin analog with high in vitro opiate activity.
DiMaio, J., & Schiller, P. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7162 · Cited by 125
Biased ligands at opioid receptors: Current status and future directions
Che, T., Dwivedi‐Agnihotri, H., Shukla, A. K., & Roth, B. L. (2021) · Science Signaling · doi:10.1126/scisignal.aav0320 · Cited by 136
ENHANCEMENT OF A NOCICEPTIVE REACTION BY OPIOID ANTAGONISTS IN MICE
Jacob, J., & Ramabadran, K. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb08645.x · Cited by 130
Ward, S. J., Portoghese, P. S., & Takemori, A. E. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90083-8 · Cited by 124
Molecular basis of opioid receptor signaling
Che, T., & Roth, B. L. (2023) · Cell · doi:10.1016/j.cell.2023.10.029 · Cited by 141
Stefano, G. B., Goumon, Y., Casares, F., Cadet, P., Fricchione, G. L., Rialas, C., Peter, D., Sonetti, D., Guarna, M., Welters, I. D., et al. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01611-8 · Cited by 117
Hökfelt, T. G. M., Broberger, C., Zhang, X., Diez, M., Kopp, J., Xu, Q., Landry, M., Bao, L., Schalling, M., Koıstınaho, J., et al. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00052-0 · Cited by 124
Facilitation of sexual behaviors in the male rat associated with Intra-VTA injections of opiates
Mitchell, J. B., & Stewart, J. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90302-x · Cited by 131
Differential postnatal development of mu and delta opiate receptors
Wohltmann, M., Roth, B. L., & Coscia, C. J. (1982) · Developmental Brain Research · doi:10.1016/0165-3806(82)90066-9 · Cited by 123
Broekkamp, C. L., Phillips, A. G., & Cools, A. R. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90137-0 · Cited by 122
The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system
Pugsley, M. K. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00165-1 · Cited by 118
Zeidan, F., Baumgartner, J. N., & Coghill, R. C. (2019) · PAIN Reports · doi:10.1097/pr9.0000000000000759 · Cited by 115
“spinal cord to reduce the elaboration of spinal and supraspinal nociceptive processing through the release of endogenous opioids(9,77,78) that largely bind with mu, delta, and kappa receptors.(54,69) Pain relief produced by placebo,(2,34,47,67,147) acupuncture,(51) conditioned pain modulation,(61) distraction,(108) an…”
BackgroundRASMUSSEN, D. D., LIU, J. H., WOLF, P. L., & YEN, S. S. C. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-5-881 · Cited by 122
Control of guinea pig intestinal electrolyte secretion by a delta-opiate receptor.
Kachur, J. F., Miller, R. J., & Field, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2753 · Cited by 121
Autoradiographic distribution of Mu1 and Mu2 opioid binding in the mouse central nervous system
Moskowitz, A. S., & Goodman, R. R. (1985) · Brain Research · doi:10.1016/0006-8993(85)91227-2 · Cited by 117
Yamamoto, L. T., Horie, S., Takayama, H., Aimi, N., Sakai, S., Yano, S., Shan, J. J., Pang, P. K. T., Ponglux, D., & Watanabe, K. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00265-1 · Cited by 119
Smith, A. P., & Lee, N. M. (1988) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.28.040188.001011 · Cited by 131
Identification of Gastrointestinal Neurotransmitters
Furness, J. B., & Costa, M. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68437-1_11 · Cited by 126
Transport of Leucine‐Enkephalin Across the Blood‐Brain Barrier in the Perfused Guinea Pig Brain
Zloković, B. V., Lipovac, M. N., Begley, D. J., Davson, H., & Rakić, L. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03431.x · Cited by 118
Uhl, G. R., NAVIA, B. A., & Douglas, J. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04755.1988 · Cited by 118
“Each peptide preferentially impacts a different group of opiate receptor subtypes, and each is expressed in distinct groups of neurons with different connectivities (Elde et al., 1976; Hokfelt et al., 1977; Lord et al., 1977; Uhl et al., 1978a, b; Snyder and Childers, 1979; Goodman et al., 1980; Graybiel et al., 1981;…”
BackgroundAllosteric coupling between morphine and enkephalin receptors in vitro.
Rothman, R. B., & Westfall, T. C. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14920-1 · Cited by 118
Development of Delta Opioid Peptides as Nonaddicting Analgesics
Rapaka, R. S., & Porreca, F. (1991) · Pharmaceutical Research · doi:10.1023/a:1015809702296 · Cited by 115
β-Endorphin and drug-induced reward and reinforcement
Roth‐Deri, I., Green-Sadan, T., & Yadid, G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.003 · Cited by 137
Opioids and their receptors: Are we there yet?
Pasternak, G. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.039 · Cited by 115
“The third member of the opioid receptor family was proposed by Kosterlitz based upon the enkephalins and termed delta (Lord et al., 1977), followed by the closely related peptide orphanin FQ/nociceptin (Meunier et al.”
BackgroundKream, R. M., Zukin, R. S., & Stefano, G. B. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70549-3 · Cited by 115
The preference of putative pro-enkephalins for different types of opiate receptors
Wüster, M., Rubini, P., & Schulz, R. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90226-5 · Cited by 114
Reisine, T. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00025-2 · Cited by 135
Dimeric tetrapeptide enkephalins display extraordinary selectivity for the δ opiate receptor
Shimohigashi, Y., Costa, T., Chen, H., & Rodbard, D. (1982) · Nature · doi:10.1038/297333a0 · Cited by 113
Management of pediatric pain with opioid analgesics
Yaster, M., & Deshpande, J. K. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80622-x · Cited by 113
Campos, A., Port, J. D., & Acosta, A. J. (2022) · Brain Sciences · doi:10.3390/brainsci12040431 · Cited by 139
Opioid receptors and endogenous opioid peptides
Simon, E. J. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110402 · Cited by 121
RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDES
Lemaire, S., MAGNAN, J., & Regoli, D. C. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb08653.x · Cited by 112
Rossier, J., French, E. D., RIVIER, C. L., Shibasaki, T., Guillemin, R., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.666 · Cited by 111
Spinal analgesia: Comparison of the mu agonist morphine and the kappa agonist ethylketazocine
Wood, P. L., Rackham, A., & Richard, J. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90618-4 · Cited by 112
Effect of Mu Opioid Receptor Blockade on Alcohol Intake in Rats Bred for High Alcohol Drinking
Krishnan-Sarin, S., Wand, G. S., Li, X.-W., Portoghese, P. S., & Froehlich, J. C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00474-7 · Cited by 110
Opioid receptor regulation of the release of norepinephrine in brain
Werling, L. L. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90077-3 · Cited by 110
Colasanti, A., Rabiner, E., Lingford-Hughes, A., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367726 · Cited by 107
“Methionineand leucine-ENK have pronounced affinity for d- and m-OR, dynorphins preferentially bind to k-OR while b-endorphin has preferential affinity for m- and d-OR (Lord et al., 1977).”
BackgroundCentrally and peripherally mediated inhibition of intestinal motility by opioids
Schulz, R., W�ster, M., & Herz, A. (1979) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00501390 · Cited by 109
“v, administration is due to activation of different opiate receptors ("multiple opiate receptors", Martin et al., 1976; Lord et al., 1977).”
BackgroundInfluence of opioids on central thermoregulatory mechanisms
Clark, W. G. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90241-7 · Cited by 109
Akiyama, K., Gee, K. W., Mosberg, H. I., Hruby, V. J., & Yamamura, H. I. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2543 · Cited by 109
Irreversible Ligands with High Selectivity Toward δ and μ Opiate Receptors
Rice, K. C., Jacobson, A. E., Burke, T. R., Bajwa, B. S., Streaty, R. A., & Klee, W. A. (1983) · Science · doi:10.1126/science.6132444 · Cited by 109
Frederickson, R. C. A., Smithwick, E. L., Shuman, R. T., & Bemis, K. G. (1981) · Science · doi:10.1126/science.6256856 · Cited by 109
Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites
Nicholson, J. R., Paterson, S. J., Menzies, J. R. W., Corbett, A. D., & McKnight, A. T. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-304 · Cited by 108
Endorphins: New Gut Peptides with a Familiar Face
Ambinder, R. F., & Schuster, M. M. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)80089-x · Cited by 107
Basak, S. C., Harriss, D. K., & Magnuson, V. R. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730403 · Cited by 107
Waterfield, A. A., Leslie, F. M., Lord, J. A. H., LING, N. C., & Kosterlitz, H. W. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90334-0 · Cited by 105
Self-citationGoodman, R. R., & Snyder, S. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5703 · Cited by 107
Metadata
- Authors
- Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W.
- Affiliations
- University of Aberdeen (GB)
- ORCID
- Lord, John A. H.
- Venue
- Nature
- Published
- 1977-06
- Volume
- 267
- Issue
- 5611
- Pages
- 495-499
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075811628
- Cited by
- 2,485
- References
- 27
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 42 · 2019: 18 · 2018: 13 · 2017: 13 · 2016: 7 · 2015: 22 · 2014: 21 · 2013: 29 · 2012: 34
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- endogenous opioids, opioid receptors, receptor agonists, naloxone binding, ileal smooth muscle contraction, vas deferens contraction, peptidergic systems
- MeSH terms
- Animals, Benzomorphans, Brain, Endorphins, Enkephalins, Guinea Pigs, Ileum, Male, Naloxone, Narcotic Antagonists, Narcotics, Oligopeptides, Peptides, Receptors, Opioid, Structure-Activity Relationship, Vas Deferens, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.